Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$346,256
+$63,085 QoQ
Shares Held
1,376
+5.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#3,493
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Physician Wealth Advisors, Inc. holds $3,911,594 across 15 Drug Manufacturers - General names. ABBV ranks #4 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,025 | $1,229,415 | |
| 2 | JNJ |
Johnson & Johnson
|
3,392 | $861,466 | |
| 3 | MRK |
Merck & Co., Inc.
|
4,682 | $601,637 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
1,376 | $346,256 | |
| 5 | NVS |
Novartis AG
|
1,603 | $251,222 | |
| 6 | PFE |
Pfizer Inc
|
10,105 | $243,328 | |
| 7 | AZN |
Astrazeneca PLC
|
492 | $93,293 | |
| 8 | AMGN |
Amgen Inc
|
235 | $85,098 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,256 | 1,376 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $283,171 | 1,302 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $282,413 | 1,236 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $222,278 | 960 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $106,917 | 576 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $106,855 | 510 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $85,118 | 479 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||